1. |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond), 2019, 39(1): 22.
|
2. |
Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: A nationwide analysis. Ann Surg Oncol, 2013, 20(9): 3023-3030.
|
3. |
黄楚坚, 蔡松华, 杜隆德, 等. 食管鳞癌以手术治疗为主的多学科治疗新研究进展. 中国癌症防治杂志, 2020, 12(4): 463-468.
|
4. |
Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol, 2012, 19(1): 68-74.
|
5. |
Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): A phase Ⅲ multicenter, randomized, open-label clinical trial. J Clin Oncol, 2018, 36(27): 2796-2803.
|
6. |
Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol, 2009, 27(30): 5062-5067.
|
7. |
Fujita Y, Hiramatsu M, Kawai M, et al. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: A retrospective study. Dis Esophagus, 2008, 21(6): 496-501.
|
8. |
程良, 高薇, 杨毫, 等. 新辅助化疗对进展期食管鳞癌的近期疗效观察. 中国肿瘤外科杂志, 2020, 12(3): 223-227.
|
9. |
Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: An eighth edition staging primer. J Thorac Oncol, 2017, 12(1): 36-42.
|
10. |
desai RK, Tagliabue JR, Wegryn SA, et al. CT evaluation of wall thickening in the alimentary tract. Radiographics, 1991, 11(5): 771-783.
|
11. |
Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg, 2004, 78(4): 1152-1160.
|
12. |
Tio TL, Cohen P, Coene PP, et al. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology, 1989, 96(6): 1478-1486.
|
13. |
Hong SJ, Kim TJ, Nam KB, et al. New TNM staging system for esophageal cancer: What chest radiologists need to know. Radiographics, 2014, 34(6): 1722-1740.
|
14. |
刘东红, 吕明德, 谢晓燕, 等. 颈部淋巴结转移的超声诊断. 中国超声医学杂志, 2001, 17(12): 921-923.
|
15. |
Therasse P. New guideline to evaluate the response to treatment in solid tumors. J Natl Cancer Inst, 2005, 12(1): S16-S27.
|
16. |
Gay JA, Dyk P, Deasy JO, et al. Common terminology criteria for adverse events (CTCAE) v4.0 based hybrid patient and physician questionnaire for head and neck (HN) radiotherapy symptom reporting. Intern J Radia Oncol Biol Phys, 2011, 81(2): S673.
|
17. |
赫捷, 李进程, 吴一龙, 等. 中国临床肿瘤学会(CSCO)食管癌诊疗指南. 北京: 人民卫生出版社, 2020.
|
18. |
郭睿, 杨勇伟, 金澄宇, 等. 食管癌淋巴结转移的危险因素分析. 中华胃食管反流病电子杂志, 2018, 5(1): 7-9.
|
19. |
van Hootegem SJM, Smithers BM, Gotley DC, et al. The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma. Ann Surg Oncol, 2019, 26(8): 2375-2384.
|
20. |
Shimodaira Y, Slack RS, Harada K, et al. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer, 2018, 118(3): 331-337.
|
21. |
杜海磊, 施敏敏, 车嘉铭, 等. 食管鳞癌肿瘤分化程度对早期食管癌患者预后的影响. 杭州: 中国医师协会胸外科医师分会2015年会、第六届全国胸外科学术大会暨第八届浙江省胸部肿瘤论坛, 2015.
|
22. |
Korst RJ, Kansler AL, Port JL, et al. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg, 2006, 82(2): 480-484.
|
23. |
叶凯, 许建华, 郑正荣, 等. 胸段食管癌孤立性淋巴结转移规律及其临床价值. 中国肿瘤临床, 2011, 38(17): 1035-1038.
|
24. |
Konishi H, Fujiwara H, Shiozaki A, et al. Effects of neoadjuvant 5-fluorouracil and cisplatin therapy in patients with clinical stage Ⅱ/Ⅲ esophageal squamous cell carcinoma. Anticancer Res, 2018, 38(2): 1017-1023.
|
25. |
Tanabe S, Shirakawa Y, Maeda N, et al. Current status of neoadjuvant chemotherapy for advanced esophageal cancer. Gan To Kagaku Ryoho, 2013, 40(12): 1612-1614.
|
26. |
Konieczny A, Meyer P, Schnider A, et al. Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. Eur Radiol, 2013, 23(9): 2492-2502.
|
27. |
Borggreve AS, Goense L, van Rossum PSN, et al. Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using 18 F-FDG PET/CT and DW-MRI: A prospective multicenter study. Int J Radiat Oncol Biol Phys, 2020, 106(5): 998-1009.
|
28. |
Peng Q, Chen H, Huo JR. Alcohol consumption and corresponding factors: A novel perspective on the risk factors of esophageal cancer. Oncol Lett, 2016, 11(5): 3231-3239.
|
29. |
Sundelöf M, Lagergren J, Ye W. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer, 2008, 44(11): 1566-1571.
|
30. |
陈洁, 袁志平. 吸烟对中晚期食管癌患者放化疗后相关并发症和相关指标及预后的影响. 东南大学学报(医学版), 2019, 38(1): 47-50.
|
31. |
孙小莉, 曹晓侠. 伴有长期吸烟史食管癌患者中 VEGF和 Ki-67水平的临床意义. 实用癌症杂志, 2015, 30(12): 1793-1796.
|
32. |
Shitara K, Matsuo K, Hatooka S, et al. Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: A retrospective study. Cancer Sci, 2010, 101(4): 1001-1006.
|
33. |
赵蓉蓉, 李文强, 王传升, 等. 酒精依赖甲基化敏感基因筛选. 中华精神科杂志, 2011, 44(4): 223-225.
|
34. |
卞保祥, 洪义东, 胡楠, 等. TFAP2E基因CpG岛甲基化状态与食管癌患者化疗疗效的关系研究. 中国现代应用药学, 2017, 34(12): 1756-1758.
|
35. |
Ebert MP, Tänzer M, Balluff B, et al. TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med, 2012, 366(1): 44-53.
|
36. |
Sun J, Du N, Li J, et al. Transcription factor AP2ε: A potential predictor of chemoresistance in patients with gastric cancer. Technol Cancer Res Treat, 2016, 15(2): 285-295.
|